Neumann, F.;                     Rose, R.;                     Römpke, J.;                     Grobe, O.;                     Lorentz, T.;                     Fickenscher, H.;                     Krumbholz, A.    
        Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination. Vaccines 2021, 9, 700.
    https://doi.org/10.3390/vaccines9070700
    AMA Style
    
                                Neumann F,                                 Rose R,                                 Römpke J,                                 Grobe O,                                 Lorentz T,                                 Fickenscher H,                                 Krumbholz A.        
                Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination. Vaccines. 2021; 9(7):700.
        https://doi.org/10.3390/vaccines9070700
    
    Chicago/Turabian Style
    
                                Neumann, Franziska,                                 Ruben Rose,                                 Janine Römpke,                                 Olaf Grobe,                                 Thomas Lorentz,                                 Helmut Fickenscher,                                 and Andi Krumbholz.        
                2021. "Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination" Vaccines 9, no. 7: 700.
        https://doi.org/10.3390/vaccines9070700
    
    APA Style
    
                                Neumann, F.,                                 Rose, R.,                                 Römpke, J.,                                 Grobe, O.,                                 Lorentz, T.,                                 Fickenscher, H.,                                 & Krumbholz, A.        
        
        (2021). Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination. Vaccines, 9(7), 700.
        https://doi.org/10.3390/vaccines9070700